Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: Progress report of a case-control study with a 5-year minimal follow-up

Journal of Nuclear Medicine

Volumn 49, Issue 3, 2008, Pages 362-366

  Boucher, Eveline ^a   Bouguen, Guillaume ^a   Garin, Etienne ^a   Guillygomarch, Anne ^b   Boudjema, Karim ^b   Raoul, Jean Luc ^a  

^a CENTRE EUGÈNE MARQUIS   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

131I labeled lipiodol; Adjuvant treatment; Internal radiotherapy; Primary liver cancer; Surgery

Indexed keywords

IODINATED POPPYSEED OIL; IODINATED POPPYSEED OIL 131; IODINATED POPPYSEED OIL I 131; IODINE 131; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DISTRIBUTION; FEMALE; FOLLOW UP; HUMAN; ISOTOPE LABELING; LIVER CELL CARCINOMA; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INJECTIONS, INTRA-ARTERIAL; IODINE RADIOISOTOPES; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 40449087801     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.044750     Document Type: Article

References (24)